Not every recombinant protein is a ready-to-use ELISA standard. A catalog protein must be qualified as a calibrator through concentration verification, standard-curve testing, and matrix-compatibility checks before it can anchor a quantitative assay. This guide covers the practical selection criteria — from UniProt accession matching to 4PL curve validation — used by assay development teams.
Quick Selection Checklist
- Target and accession: confirm the exact UniProt accession, isoform, and sequence range of your analyte
- Species match: human analyte → human standard; avoid cross-species substitutions in quantitative assays
- Full-length vs. fragment: full-length for sandwich ELISA coverage; fragments only if the capture/detection antibody pair is mapped to that region
- Expression system: E. coli for non-glycosylated analytes; mammalian cells when glycosylation affects antibody recognition
- Tag: tag-free preferred for standards; His-tag is usually acceptable; Fc-tag can interfere with anti-Fc detection
- Purity: greater than 90% by SDS-PAGE; request HPLC data for critical quantitation
- Concentration determination: A280 or BCA — verify the method and buffer compatibility (detergents and reducing agents interfere with BCA/Bradford)
- Formulation: carrier-free for standards; BSA-containing buffers will contaminate the calibrator
- Endotoxin: <1 EU/μg for cell-based assays downstream of ELISA
- Lot documentation: request the Certificate of Analysis and reserve a single lot for the full development cycle
Match the Recombinant Protein to the ELISA Analyte
The single most common ELISA failure is a standard that does not match the analyte. Verify:
- UniProt accession and isoform: isoform differences change epitopes, molecular weight, and antibody recognition
- Signal peptide removal: confirm the mature sequence range — standards expressed with the signal peptide produce incorrect quantitation
- Post-translational modifications: glycosylation can mask or expose epitopes recognized by your antibody pair
- Oligomeric state: dimeric or trimeric analytes (e.g., TNF-α homotrimer) must be matched by the standard’s assembly state
Full-Length vs. Fragment Standards
For sandwich ELISA with two antibodies targeting different epitopes, a full-length standard is preferred — fragments may lack one of the epitopes and produce false low recovery. Fragments are acceptable when the antibody pair is mapped to the same region, or in competitive ELISA formats where a single epitope drives the assay.
Expression System Considerations
| System | When to use for ELISA standards |
|---|---|
| E. coli | Non-glycosylated analytes (most cytokines: IL-2, IL-6, IL-8, TNF-α); most cost-effective |
| Yeast | Secreted cytokines when E. coli refolding fails |
| Mammalian (HEK293/CHO) | Glycosylated analytes where antibodies were raised against native protein |
Example: antibodies raised against mammalian IL-6 may not recognize E. coli-expressed IL-6 identically. If your antibody pair was developed against a mammalian antigen, match the expression system.
Tag-Free vs. Tagged Standards
For quantitation, tag-free is preferred. His-tags (6-10 residues) rarely affect antibody recognition and are acceptable. Avoid Fc-tagged proteins as standards when your detection system uses anti-Fc antibodies, and avoid biotinylated standards unless the assay design specifically uses streptavidin capture.
Purity, Identity, and Concentration
- Purity: greater than 90% by SDS-PAGE minimum; for certified-level quantitation, request HPLC or mass-spec characterization
- Identity: confirm molecular weight (predicted vs. observed) — a shifted band indicates degradation or aggregation
- Concentration: A280 (UV) is the most reliable for pure proteins. BCA and Bradford are affected by buffer components (Tris, detergents, reducing agents). If the standard ships with an A280-determined concentration, use that value for curve preparation
Qualify the Candidate Calibrator
Before committing to a lot, run the six qualification steps:
- Curve range: titrate the standard to define the working range (typically 10–12 points, 2-fold serial dilution)
- Curve model: fit 4-parameter logistic (4PL) or 5PL; 5PL handles asymmetric curves better
- Precision: CV <20% at LLOQ and ULOQ, <15% across the range
- Spike recovery: spike known concentrations into sample matrix; recovery 80–120% is acceptable
- Dilutional parallelism: serially diluted samples must parallel the standard curve — non-parallelism indicates matrix interference or analyte mismatch
- Sensitivity: confirm LLOQ meets assay requirements in the actual sample matrix
Lot-to-Lot Consistency
Reserve a single production lot for the complete assay development and validation cycle. When switching lots, run a bridging study: test the new lot against the old on the same plate across the full curve. BioCrest Sci provides lot-specific Certificates of Analysis and supports bulk lot reservation for assay developers.
FAQ
Can any recombinant protein be used as an ELISA standard?
No. A protein becomes a quantitative standard only after concentration verification, curve testing, and matrix qualification. Catalog proteins are candidate calibrators — qualify them before use.
Should I use a lyophilized or liquid standard?
Lyophilized is preferred for long-term stability and shipping; reconstitute per the datasheet and aliquot immediately. Liquid formats are convenient for frequent use but verify stability under your storage conditions.
What if my spike recovery is outside 80–120%?
Suspect matrix effects first (test the standard in assay diluent vs. sample matrix), then analyte mismatch (isoform or PTM differences), then antibody pair specificity.
References
- Andreasson U, et al. A practical guide to immunoassay method validation. Front Neurol. 2015;6:179.
- Findlay JW, Dillard RF. Appropriate calibration curve fitting in ligand binding assays. AAPS J. 2007;9(2):E260-7.
By BioCrest Sci Research Team. Last reviewed August 2026.
Browse high-purity recombinant proteins for assay development, or explore our technical resource guides. For help matching a standard to your analyte, contact sales@biocrestsci.com.